Grants > The Role of Gene Dosage in Autosomal Dominant Glaucoma
Updated On: Oct 2, 2026
National Glaucoma Research Grant
The Role of Gene Dosage in Autosomal Dominant Glaucoma
About the Research Project
Program
National Glaucoma Research
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 1996 - March 31, 1998
Grant ID
G1996420
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
The Immune Landscape of the Human Optic Nerve Head
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Monica Vetter, PhD
Current Organization
University of Utah
The Immune Landscape of the Human Optic Nerve Head
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Monica Vetter, PhD
Current Organization
University of Utah
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute